Antibody-drug conjugates in breast cancer: From therapeutic and immune activation mechanisms to resistance prevention
用户iQXgRwYGcNXs
10天前
32
10
已关闭
DOI:
文献链接:
其他信息:
NMA Nik Amirah Auni, N Mohd Redzwan…
International Reviews …, 2025
Taylor & Francis
… (Dato-DXd) and ladiratuzumab vedotin (LV). Preclinical and clinical … (Dato-DXd) and ladiratuzumab vedotin (LV). These ADCs … -4, JIMT1, and Capan-1 with different expression of …